BP003331: Human HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*11:01&B2M&KRAS G12S (VVVGASGVGK) Tetramer Protein, (amino acids Gly25-Thr305(HLA-A*11:01), Ile21-Met119(B2M) and VVVGASGVGK peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP003509: Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein with the C-His-Avi Tag
Source: The recombinant Human HLA-A*02:01&B2M&PRAME (SLLQHLIGL) Monomer Protein, (amino acids Gly25-Thr305(HLA-A*02:01), Ile21-Met119(B2M)and SLLQHLIGL peptide) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity:
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP005431: Human TSLP (R127A, R130A) Protein with the C-His-Avi Tag
Source: The recombinant Human TSLP (R127A, R130A) Protein, (amino acids Tyr29-Gln159(R127A,R130A)) fused with a His-Avi tag at the C-terminus, was produced in HEK 293 cells.
Activity: Immobilized recombinant Human TSLP (R127A, R130A) protein with the C-His-Avi tag at 2 ug/ml (100 ul/Well). Dose response curve for the recombinant Human TSLPR protein with the C-hFc tag with the EC50 of 4.0 ng/ml determined by ELISA (QC Test).
Purity: >95% by SEC-HPLC and SDS-PAGE under reducing conditions.
Endotoxin Level: Less than 1 EU per ug of protein as determined by LAL method.BP001517-C227: Recombinant Human Glial fibrillary acidic protein (GFAP) Protein
Source: E. coli-derived.
Purity: > 95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001681-CE67: Recombinant Human Desmin (DES) Protein
Source: E. coli-derived.
Purity: >95% by reducing SDS-PAGE.
Endotoxin: < 0.1 ng/ug (1 IEU/ug).BP001681-PRO-520: Recombinant Human Desmin (DES) Protein
Source: E. coli-derived.
Purity: >95% by RP-HPLC and SDS-PAGE.